A Reappraisal of Circulating Fetal Cell Noninvasive Prenatal Testing.

New tools for higher-resolution fetal genome analysis including microarray and next-generation sequencing have revolutionized prenatal screening. This article provides commentary on this rapidly advancing field and a future perspective emphasizing circulating fetal cell (CFC) utility. Despite the tremendous technological challenges associated with their reliable and cost-effective isolation from maternal blood, CFCs have a strong potential to bridge the gap between the diagnostic sensitivity of invasive procedures and the desirable noninvasive nature of cell-free fetal DNA (cffDNA). Considering the rapid advances in both rare cell isolation and low-input DNA analysis, we argue here that CFC-based noninvasive prenatal testing is poised to be implemented clinically in the near future.

[1]  Ripudaman Singh,et al.  Genome‐wide copy number analysis on DNA from fetal cells isolated from the blood of pregnant women , 2016, Prenatal diagnosis.

[2]  Committee Opinion Summary No. 640: Cell-Free DNA Screening For Fetal Aneuploidy. , 2015, Obstetrics and gynecology.

[3]  R. Favre,et al.  Cell-Free DNA Analysis in Maternal Plasma in Cases of Fetal Abnormalities Detected on Ultrasound Examination , 2015, Obstetrics and gynecology.

[4]  R. Stokowski,et al.  Clinical performance of non‐invasive prenatal testing (NIPT) using targeted cell‐free DNA analysis in maternal plasma with microarrays or next generation sequencing (NGS) is consistent across multiple controlled clinical studies , 2015, Prenatal diagnosis.

[5]  Michael Hertz,et al.  Fetal genome profiling at 5 weeks of gestation after noninvasive isolation of trophoblast cells from the endocervical canal , 2016, Science Translational Medicine.

[6]  Jeff E. Mold,et al.  Comparison of whole genome amplification techniques for human single cell exome sequencing , 2017, PloS one.

[7]  Benjamin Thierry,et al.  Isolation of Circulating Fetal Trophoblasts Using Inertial Microfluidics for Noninvasive Prenatal Testing , 2018, Advanced Materials Technologies.

[8]  W. Holzgreve,et al.  Georg Schmorl on trophoblasts in the maternal circulation. , 2007, Placenta.

[9]  D. McMullan,et al.  Use of prenatal chromosomal microarray: prospective cohort study and systematic review and meta‐analysis , 2013, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[10]  Masahito Hosokawa,et al.  Massively parallel whole genome amplification for single-cell sequencing using droplet microfluidics , 2017, Scientific Reports.

[11]  A. Barrett,et al.  Non‐invasive prenatal testing for fetal inheritance of maternal β‐thalassaemia mutations using targeted sequencing and relative mutation dosage: a feasibility study , 2018, BJOG : an international journal of obstetrics and gynaecology.

[12]  E. de Bruijn,et al.  Sensitive Monogenic Noninvasive Prenatal Diagnosis by Targeted Haplotyping , 2017, American journal of human genetics.

[13]  D. Bianchi,et al.  Noninvasive Prenatal DNA Testing: The Vanguard of Genomic Medicine. , 2017, Annual review of medicine.

[14]  M. Lutgendorf,et al.  Noninvasive prenatal testing: limitations and unanswered questions , 2013, Genetics in Medicine.

[15]  Hojae Lee,et al.  Noninvasive Prenatal Diagnosis of Single-Gene Disorders by Use of Droplet Digital PCR. , 2018, Clinical chemistry.

[16]  I. B. Van den Veyver,et al.  Recent advances in prenatal genetic screening and testing , 2016, F1000Research.

[17]  B. Huppertz,et al.  Trophoblast retrieval and isolation from the cervix: origins of cervical trophoblasts and their potential value for risk assessment of ongoing pregnancies , 2018, Human reproduction update.

[18]  Ali Asgar S. Bhagat,et al.  Clinical Validation of an Ultra High-Throughput Spiral Microfluidics for the Detection and Enrichment of Viable Circulating Tumor Cells , 2014, PloS one.

[19]  M. Halks-Miller,et al.  Noninvasive prenatal testing in the general obstetric population: clinical performance and counseling considerations in over 85 000 cases† , 2016, Prenatal diagnosis.

[20]  Abdur Rahman,et al.  Lab-on-a-chip technology: impacting non-invasive prenatal diagnostics (NIPD) through miniaturisation. , 2014, Lab on a chip.

[21]  R. Tompkins,et al.  A microfluidics approach for the isolation of nucleated red blood cells (NRBCs) from the peripheral blood of pregnant women , 2008, Prenatal diagnosis.

[22]  M. Hurles,et al.  Prenatal exome sequencing for fetuses with structural abnormalities: the next step , 2015, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[23]  Peiyong Jiang,et al.  Second generation noninvasive fetal genome analysis reveals de novo mutations, single-base parental inheritance, and preferred DNA ends , 2016, Proceedings of the National Academy of Sciences.

[24]  F. D’Antonio,et al.  Procedure‐related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta‐analysis , 2015, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[25]  A. Barrett,et al.  Non-invasive prenatal diagnosis of achondroplasia and thanatophoric dysplasia: next-generation sequencing allows for a safer, more accurate, and comprehensive approach , 2015, Prenatal diagnosis.

[26]  A. Kan,et al.  A case of prenatal isolated talipes and 22q11.2 deletion syndrome—an important chromosomal disorder missed by noninvasive prenatal screening , 2018, Prenatal diagnosis.

[27]  R. Grivell,et al.  Noninvasive prenatal testing. , 2014, Australian family physician.

[28]  C. Lim,et al.  Single‐cell profiling approaches to probing tumor heterogeneity , 2016, International journal of cancer.

[29]  W. Dondorp,et al.  Arrays in postnatal and prenatal diagnosis: An exploration of the ethics of consent , 2012, Human Mutation.

[30]  C. Cantor,et al.  Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma , 2008, Proceedings of the National Academy of Sciences.

[31]  M. Trujillo-Tiebas,et al.  Non-invasive prenatal diagnosis of single-gene disorders from maternal blood. , 2012, Gene.

[32]  N. Uldbjerg,et al.  Characterization of Fetal Cells from the Maternal Circulation by Microarray Gene Expression Analysis - Could the Extravillous Trophoblasts Be a Target for Future Cell-Based Non-Invasive Prenatal Diagnosis? , 2013, Fetal Diagnosis and Therapy.

[33]  K. Nicolaides,et al.  Detection of circulating fetal cells utilizing automated microscopy: potential for noninvasive prenatal diagnosis of chromosomal aneuploidies , 2008, Prenatal diagnosis.

[34]  L. Hui,et al.  Noninvasive prenatal testing for trisomy 21: Challenges for implementation in Australia , 2013, The Australian & New Zealand journal of obstetrics & gynaecology.

[35]  Xu Li,et al.  Detection of trisomies 13, 18 and 21 using non-invasive prenatal testing , 2017, Experimental and therapeutic medicine.

[36]  K. Klinger,et al.  Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data , 2002, Prenatal diagnosis.

[37]  Chad A. Shaw,et al.  Evidence for feasibility of fetal trophoblastic cell‐based noninvasive prenatal testing† , 2016, Prenatal diagnosis.

[38]  S. Drury,et al.  Non‐invasive prenatal diagnosis (NIPD) for single gene disorders: cost analysis of NIPD and invasive testing pathways , 2016, Prenatal diagnosis.

[39]  Bernard Lacour,et al.  Circulating trophoblastic cells provide genetic diagnosis in 63 fetuses at risk for cystic fibrosis or spinal muscular atrophy. , 2012, Reproductive biomedicine online.

[40]  L. Vissers,et al.  Genetic studies in intellectual disability and related disorders , 2015, Nature Reviews Genetics.

[41]  Tai-ping Lee,et al.  Noninvasive prenatal diagnosis. , 2015, Taiwanese journal of obstetrics & gynecology.

[42]  D. Ledbetter,et al.  Chromosomal microarray versus karyotyping for prenatal diagnosis. , 2012, The New England journal of medicine.

[43]  K. Nicolaides,et al.  Fetal fraction in maternal plasma cell‐free DNA at 11–13 weeks' gestation: relation to maternal and fetal characteristics , 2013, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[44]  K. Nicolaides,et al.  Analysis of cell‐free DNA in maternal blood in screening for fetal aneuploidies: updated meta‐analysis , 2015, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[45]  Committee Opinion No. 581: the use of chromosomal microarray analysis in prenatal diagnosis. , 2013, Obstetrics and gynecology.

[46]  T. Gerds,et al.  Risk of fetal loss associated with invasive testing following combined first‐trimester screening for Down syndrome: a national cohort of 147 987 singleton pregnancies , 2016, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[47]  N. Vora,et al.  Promises, pitfalls and practicalities of prenatal whole exome sequencing , 2018, Prenatal diagnosis.

[48]  C. Yang,et al.  Frequency-enhanced transferrin receptor antibody-labelled microfluidic chip (FETAL-Chip) enables efficient enrichment of circulating nucleated red blood cells for non-invasive prenatal diagnosis. , 2018, Lab on a chip.

[49]  Ali Bashashati,et al.  Robust high-performance nanoliter-volume single-cell multiple displacement amplification on planar substrates , 2016, Proceedings of the National Academy of Sciences.

[50]  Yama W. L. Zheng,et al.  Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study , 2011, BMJ : British Medical Journal.

[51]  Shuang Hou,et al.  Imprinted NanoVelcro Microchips for Isolation and Characterization of Circulating Fetal Trophoblasts: Toward Noninvasive Prenatal Diagnostics. , 2017, ACS nano.

[52]  H. C. Fan,et al.  Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood , 2008, Proceedings of the National Academy of Sciences.

[53]  M. Watson,et al.  Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics , 2016, Genetics in Medicine.

[54]  Dino Di Carlo,et al.  Label-free isolation of prostate circulating tumor cells using Vortex microfluidic technology , 2017, npj Precision Oncology.

[55]  L. Wilkins-Haug,et al.  Integration of noninvasive DNA testing for aneuploidy into prenatal care: what has happened since the rubber met the road? , 2014, Clinical chemistry.

[56]  D. Cram,et al.  Potential of syncytiotrophoblasts isolated from the cervical mucus for early non-invasive prenatal diagnosis: evidence of a vanishing twin. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[57]  H. Jou,et al.  Noninvasive prenatal diagnosis of fetal aneuploidy by circulating fetal nucleated red blood cells and extravillous trophoblasts using silicon-based nanostructured microfluidics , 2017, Molecular Cytogenetics.

[58]  K. Nicolaides,et al.  Validation of targeted sequencing of single‐nucleotide polymorphisms for non‐invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y , 2013, Prenatal diagnosis.

[59]  S. Langlois,et al.  Non-invasive prenatal testing for fetal chromosome abnormalities: review of clinical and ethical issues , 2016, The application of clinical genetics.

[60]  T. Okai,et al.  Development of noninvasive fetal DNA diagnosis from nucleated erythrocytes circulating in maternal blood , 2007, Prenatal diagnosis.

[61]  N. Uldbjerg,et al.  On the road to replacing invasive testing with cell‐based NIPT: Five clinical cases with aneuploidies, microduplication, unbalanced structural rearrangement, or mosaicism , 2017, Prenatal diagnosis.

[62]  B. Waters,et al.  First‐trimester diagnosis of Meckel–Gruber syndrome by fetal ultrasound with molecular identification of CC2D2A mutations by next‐generation sequencing , 2014, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[63]  N. Uldbjerg,et al.  A new marker set that identifies fetal cells in maternal circulation with high specificity , 2014, Prenatal diagnosis.

[64]  P. Benn.  Expanding non‐invasive prenatal testing beyond chromosomes 21, 18, 13, X and Y , 2016, Clinical genetics.

[65]  Y. Gao,et al.  Non‐invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146 958 pregnancies , 2015, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[66]  Practice Bulletin No. 162: Prenatal Diagnostic Testing for Genetic Disorders , 2016, Obstetrics and gynecology.

[67]  Koenraad Devriendt,et al.  Prenatal and pre-implantation genetic diagnosis , 2016, Nature Reviews Genetics.

[68]  D. Hendrie,et al.  Prenatal screening for Down syndrome in Australia: Costs and benefits of current and novel screening strategies , 2013, The Australian & New Zealand journal of obstetrics & gynaecology.

[69]  Lars Bolund,et al.  Isolation and whole genome sequencing of fetal cells from maternal blood towards the ultimate non‐invasive prenatal testing , 2017, Prenatal diagnosis.

[70]  J. Hewitt,et al.  Non-invasive prenatal diagnosis of spinal muscular atrophy by relative haplotype dosage , 2017, European Journal of Human Genetics.